Impact of type 1 and type 2 diabetes on patterns and costs of drug prescribing: a population-based study.
JEFF EVANS(Intermountain Healthcare), Andrew D. Morris(Health Data Research UK), Graham Leese(NHS Tayside), Thomas M. MacDonald(Ninewells Hospital), Danny Ruta(University of Dundee)
Cited by 32
Related Papers
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout
|Nature Genetics|2008|806
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes
|Nature Genetics|2007|725
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
|The Lancet Diabetes & Endocrinology|2018|340
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel
|Annals of the Rheumatic Diseases|2010|105